RGNX · REGENXBIO Inc. · Held by Funds
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about our ability to continue as a going concern within 12 months from the issuance date of our consolidated financial statements for the three and nine months ended September 30, 2026 included in this Quarterly Report on Form 10-Q.”View the 10-Q filed Nov 5, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Fund Ownership of RGNX by Fund Type
Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026Index funds and index ETFs hold 13.53% of shares outstanding.
| Fund type | Of shares outstanding | Shares |
|---|---|---|
| Index funds | 2.56% | 1,693,174 |
| Index ETFs | 10.97% | 7,251,721 |
| Active ETFs | 1.04% | 689,096 |
| Active funds | 6.86% | 4,533,101 |
| Unclassified | 0.15% | 102,083 |
| All registered funds | 21.58% | 14,269,175 |
How fund types are measured
Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.
Funds holding RGNX
191 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| State Street(R) SPDR(R) S&P(R) Biotech ETF | XBI | 1,958,976 | $23,468,532 | 0.22% | Long | 2026-06-30 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 1,496,139 | $17,923,745 | 0.00% | Long | 2026-06-30 | |
| iShares Russell 2000 ETF | IWM | 1,270,455 | $15,220,051 | 0.02% | Long | 2026-06-30 | |
| Nuveen Quant Small Cap Equity Fund | — | 855,170 | $8,286,597 | 0.20% | Long | 2026-07-31 | |
| JPMorgan Small Cap Growth Fund | — | 629,843 | $7,545,519 | 0.29% | Long | 2026-06-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 564,476 | $6,762,422 | 0.01% | Long | 2026-06-30 | |
| VANGUARD STRATEGIC SMALL-CAP EQUITY FUND | VSTCX | 467,248 | $5,597,631 | 0.18% | Long | 2026-06-30 | |
| Fidelity Small Cap Index Fund | FSSNX | 527,935 | $5,115,690 | 0.02% | Long | 2026-07-31 | |
| BlackRock Advantage Small Cap Core Fund | — | 537,046 | $5,101,937 | 0.09% | Long | 2026-08-31 | |
| iShares Russell 2000 Growth ETF | IWO | 378,118 | $4,529,854 | 0.03% | Long | 2026-06-30 | |
| iShares Biotechnology ETF | IBB | 336,179 | $4,027,424 | 0.04% | Long | 2026-06-30 | |
| Fidelity Enhanced Small Cap Core ETF | FESM | 322,770 | $3,866,785 | 0.07% | Long | 2026-06-30 | |
| VANGUARD MARKET NEUTRAL FUND | — | 281,985 | $3,378,180 | 0.57% | Long | 2026-06-30 | |
| VANGUARD RUSSELL 2000 INDEX FUND | — | 276,412 | $2,625,914 | 0.01% | Long | 2026-08-31 | |
| JPMorgan Small Cap Blend Fund | — | 200,197 | $2,398,360 | 0.14% | Long | 2026-06-30 | |
| Fidelity Extended Market Index Fund | FSMAX | 242,292 | $2,301,774 | 0.01% | Long | 2026-08-31 | |
| Schwab U.S. Small-Cap ETF | SCHA | 234,362 | $2,226,439 | 0.01% | Long | 2026-08-31 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 214,663 | $2,039,299 | 0.03% | Long | 2026-08-31 | |
| JPMorgan Small Cap Value Fund | — | 167,997 | $2,012,604 | 0.15% | Long | 2026-06-30 | |
| VANGUARD EXPLORER FUND | — | 185,846 | $1,800,848 | 0.01% | Long | 2026-07-31 | |
| Nomura Healthcare Fund | — | 149,000 | $1,785,020 | 0.24% | Long | 2026-06-30 | |
| Multi-Manager Small Cap Equity Strategies Fund | CZMSX | 170,371 | $1,618,525 | 0.14% | Long | 2026-08-31 | |
| Strategic Advisers U.S. Total Stock Fund | FSAKX | 159,350 | $1,513,825 | 0.00% | Long | 2026-08-31 | |
| Dimensional U.S. Core Equity 2 ETF | DFAC | 145,383 | $1,408,761 | 0.00% | Long | 2026-07-31 | |
| JPMorgan U.S. Small Company Fund | — | 111,622 | $1,337,232 | 0.12% | Long | 2026-06-30 | |
| SPDR(R) S & P 600 Small Cap ETF | SLY | 70,584 | $1,334,743 | 0.08% | Long | 2023-03-31 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 133,551 | $1,268,735 | 0.01% | Long | 2026-08-31 | |
| iShares Core S&P Total U.S. Stock Market ETF | ITOT | 100,565 | $1,204,769 | 0.00% | Long | 2026-06-30 | |
| Schwab Small-Cap Index Fund | SWSSX | 116,373 | $1,127,654 | 0.01% | Long | 2026-07-31 | |
| Master Small Cap Index Series | — | 91,192 | $1,092,480 | 0.02% | Long | 2026-06-30 | |
| U.S. MICRO CAP PORTFOLIO | DFSCX | 111,201 | $1,077,538 | 0.01% | Long | 2026-07-31 | |
| BlackRock Advantage Small Cap Growth Fund | — | 89,187 | $1,068,460 | 0.13% | Long | 2026-06-30 | |
| Invesco RAFI US 1500 Small-Mid ETF | PRFZ | 105,503 | $1,022,324 | 0.04% | Long | 2026-07-31 | |
| BlackRock Health Sciences Term Trust | BMEZ | 81,282 | $973,758 | 0.09% | Long | 2026-06-30 | |
| U.S. SMALL CAP PORTFOLIO | DFSTX | 98,060 | $950,201 | 0.00% | Long | 2026-07-31 | |
| iShares Russell 2000 Value ETF | IWN | 73,485 | $880,350 | 0.01% | Long | 2026-06-30 | |
| Fidelity Total Market Index Fund | FSKAX | 88,913 | $844,674 | 0.00% | Long | 2026-08-31 | |
| BlackRock Advantage SMID Cap Fund, Inc. | — | 62,212 | $745,300 | 0.08% | Long | 2026-06-30 | |
| Fidelity Series Total Market Index Fund | FCFMX | 74,961 | $712,130 | 0.00% | Long | 2026-08-31 | |
| VANGUARD GROWTH AND INCOME FUND | — | 57,101 | $684,070 | 0.00% | Long | 2026-06-30 | |
| MFS Blended Research Small Cap Equity Fund | — | 68,841 | $653,990 | 0.20% | Long | 2026-08-31 | |
| Direxion Daily S&P Biotech Bull 3X Shares | LABU | 66,560 | $644,966 | 0.13% | Long | 2026-07-31 | |
| Nuveen Small Cap Blend Index Fund | — | 64,225 | $622,340 | 0.02% | Long | 2026-07-31 | |
| EQ/2000 Managed Volatility Portfolio | — | 49,211 | $589,548 | 0.02% | Long | 2026-06-30 | |
| Diversified Equity Alpha Master Portfolio | — | 48,226 | $577,747 | 0.02% | Long | 2026-06-30 | |
| JPMorgan Small Cap Value Portfolio | — | 41,325 | $495,074 | 0.15% | Long | 2026-06-30 | |
| Virtus Biotech Clinical Trials Etf | BBC | 46,670 | $452,232 | 0.97% | Long | 2026-07-31 | |
| Fidelity Small Cap Growth Index Fund | FECGX | 37,731 | $452,017 | 0.03% | Long | 2026-06-30 | |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND | — | 44,023 | $418,219 | 0.02% | Long | 2026-08-31 | |
| EQ/Small Company Index Portfolio | — | 33,030 | $395,699 | 0.02% | Long | 2026-06-30 |